Natalie L. Trevaskis

8.3k total citations · 5 hit papers
84 papers, 5.8k citations indexed

About

Natalie L. Trevaskis is a scholar working on Oncology, Molecular Biology and Pharmaceutical Science. According to data from OpenAlex, Natalie L. Trevaskis has authored 84 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Oncology, 25 papers in Molecular Biology and 23 papers in Pharmaceutical Science. Recurrent topics in Natalie L. Trevaskis's work include Drug Transport and Resistance Mechanisms (22 papers), Lymphatic System and Diseases (16 papers) and Drug Solubulity and Delivery Systems (15 papers). Natalie L. Trevaskis is often cited by papers focused on Drug Transport and Resistance Mechanisms (22 papers), Lymphatic System and Diseases (16 papers) and Drug Solubulity and Delivery Systems (15 papers). Natalie L. Trevaskis collaborates with scholars based in Australia, United States and New Zealand. Natalie L. Trevaskis's co-authors include Christopher J. H. Porter, William N. Charman, Colin W. Pouton, Hywel D. Williams, Ravi Shanker, Susan A. Charman, Lisa M. Kaminskas, Sifei Han, Matthew Crum and Orlagh M. Feeney and has published in prestigious journals such as Angewandte Chemie International Edition, SHILAP Revista de lepidopterología and Nature Reviews Drug Discovery.

In The Last Decade

Natalie L. Trevaskis

81 papers receiving 5.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs

2007 1.4k citations Christopher J. H. Porter, Natalie L. Trevaskis et al. profile →
Strategies to Address Low Drug Solubility in Discovery and Development

2013 1.3k citations Natalie L. Trevaskis, William N. Charman et al. Pharmacological Reviews profile →
From sewer to saviour — targeting the lymphatic system to promote drug exposure and activity

2015 517 citations Natalie L. Trevaskis, Christopher J. H. Porter et al. profile →
50 years of oral lipid-based formulations: Provenance, progress and future perspectives

2016 340 citations Orlagh M. Feeney, Natalie L. Trevaskis et al. profile →
From influenza to COVID-19: Lipid nanoparticle mRNA vaccines at the frontiers of infectious diseases

2021 187 citations Natalie L. Trevaskis et al. Acta Biomaterialia profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Natalie L. Trevaskis Australia	30	2.9k	1.5k	1.1k	915	609	84	5.8k
Shinji Yamashita Japan	42	2.9k 1.0×	1.4k 0.9×	1.6k 1.4×	862 0.9×	431 0.7×	167	5.8k
Alfred Fahr Germany	44	2.6k 0.9×	2.7k 1.8×	567 0.5×	622 0.7×	909 1.5×	180	7.1k
Ramesh Panchagnula India	42	2.6k 0.9×	1.0k 0.7×	737 0.7×	418 0.5×	911 1.5×	125	5.2k
Martin Brandl Denmark	41	2.6k 0.9×	1.9k 1.3×	660 0.6×	865 0.9×	1.1k 1.7×	155	5.3k
René Holm Denmark	46	4.7k 1.6×	1.9k 1.3×	1.1k 1.0×	1.9k 2.1×	698 1.1×	266	8.3k
Kazutaka Higaki Japan	37	2.0k 0.7×	1.3k 0.9×	756 0.7×	653 0.7×	1.1k 1.8×	167	5.0k
Marival Bermejo Spain	34	1.8k 0.6×	1.0k 0.7×	1.1k 0.9×	644 0.7×	310 0.5×	143	4.6k
Amnon Hoffman Israel	45	2.3k 0.8×	2.2k 1.5×	994 0.9×	293 0.3×	366 0.6×	138	6.3k
John R. Crison United States	20	3.4k 1.2×	941 0.6×	922 0.8×	1.5k 1.7×	245 0.4×	31	5.3k
Susan A. Charman Australia	46	1.7k 0.6×	2.2k 1.5×	758 0.7×	796 0.9×	267 0.4×	152	7.6k

Countries citing papers authored by Natalie L. Trevaskis

Since Specialization

Citations

This map shows the geographic impact of Natalie L. Trevaskis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natalie L. Trevaskis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natalie L. Trevaskis more than expected).

Fields of papers citing papers by Natalie L. Trevaskis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Natalie L. Trevaskis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natalie L. Trevaskis. The network helps show where Natalie L. Trevaskis may publish in the future.

Co-authorship network of co-authors of Natalie L. Trevaskis

This figure shows the co-authorship network connecting the top 25 collaborators of Natalie L. Trevaskis. A scholar is included among the top collaborators of Natalie L. Trevaskis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Natalie L. Trevaskis. Natalie L. Trevaskis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Hu, Luojuan, Tim Quach, Dan Zheng, et al.. (2025). Optimizing Triglyceride Prodrugs of a Model Immunomodulator: Conjugation through the Phenol of Mycophenolic Acid (MPA) Markedly Promotes Lymphatic Drug Transport. Molecular Pharmaceutics. 22(3). 1555–1567.

2.

Abdallah, Mohammad, Sifei Han, Luojuan Hu, et al.. (2024). Intestinal Lymphatic Biology, Drug Delivery, and Therapeutics: Current Status and Future Directions. Pharmacological Reviews. 76(6). 1326–1398. 1 indexed citations

3.

Cao, Enyuan, Dovile Anderson, Joel Schmitz, et al.. (2024). High-fat feeding drives the intestinal production and assembly of C _16:0 ceramides in chylomicrons. Science Advances. 10(34). eadp2254–eadp2254. 2 indexed citations

4.

Phillips, Anthony R.J., et al.. (2024). Lymphatic Uptake of a Highly Lipophilic Protease Inhibitor Prodrug from a Lipid-Based Formulation is Limited by Instability in the Intestine. Journal of Pharmaceutical Sciences. 113(8). 2342–2351.

5.

Abdallah, Mohammad, et al.. (2024). Lymphatic uptake of the lipidated and non-lipidated GLP-1 agonists liraglutide and exenatide is similar in rats. European Journal of Pharmaceutics and Biopharmaceutics. 200. 114339–114339. 6 indexed citations

6.

Cao, Enyuan, et al.. (2024). Quantifying the Lymphatic Transport of Model Therapeutics from the Brain in Rats. Molecular Pharmaceutics. 21(5). 2473–2483. 1 indexed citations

7.

Jin, Liang, et al.. (2024). Acute Neuroinflammation Alters the Transport of a Model Therapeutic Protein from the Brain into Lymph and Blood. Molecular Pharmaceutics. 21(10). 5138–5149. 1 indexed citations

8.

Farooq, Muhammad Asim, Angus P. R. Johnston, & Natalie L. Trevaskis. (2024). Impact of nanoparticle properties on immune cell interactions in the lymph node. Acta Biomaterialia. 193. 65–82. 9 indexed citations

9.

Cao, Enyuan, et al.. (2023). Development and application of a novel cervical lymph collection method to assess lymphatic transport in rats. Frontiers in Pharmacology. 14. 1111617–1111617. 5 indexed citations

10.

Senyschyn, Danielle, Enyuan Cao, Mohammad Abdallah, et al.. (2023). Intra-articular Injection of a B Cell Depletion Antibody Enhances Local Exposure to the Joint-Draining Lymph Node in Mice with Collagen-Induced Arthritis. Molecular Pharmaceutics. 20(4). 2053–2066. 3 indexed citations

11.

Han, Sifei, Tim Quach, Luojuan Hu, et al.. (2023). Increasing Linker Chain Length and Intestinal Stability Enhances Lymphatic Transport and Lymph Node Exposure of Triglyceride Mimetic Prodrugs of a Model Immunomodulator Mycophenolic Acid. Molecular Pharmaceutics. 20(5). 2675–2685. 4 indexed citations

12.

Abdallah, Mohammad, Cameron J. Nowell, John F. Quinn, et al.. (2023). Functionalisation of brush polyethylene glycol polymers with specific lipids extends their elimination half-life through association with natural lipid trafficking pathways. Acta Biomaterialia. 174. 191–205. 8 indexed citations

13.

Kumar, Anupama, Faheem Faheem, Sankaranarayanan Murugesan, et al.. (2022). CoviRx: A User-Friendly Interface for Systematic Down-Selection of Repurposed Drug Candidates for COVID-19. Data. 7(11). 164–164. 4 indexed citations

14.

MacRaild, Christopher A., Faheem Faheem, Sankaranarayanan Murugesan, et al.. (2022). Systematic Down-Selection of Repurposed Drug Candidates for COVID-19. International Journal of Molecular Sciences. 23(19). 11851–11851. 3 indexed citations

15.

Mikrani, Reyaj, Mohammad Abdallah, Danielle Senyschyn, et al.. (2022). Obesity-associated mesenteric lymph leakage impairs the trafficking of lipids, lipophilic drugs and antigens from the intestine to mesenteric lymph nodes. European Journal of Pharmaceutics and Biopharmaceutics. 180. 319–331. 2 indexed citations

16.

Cao, Enyuan, et al.. (2020). High-Density Lipoprotein Composition Influences Lymphatic Transport after Subcutaneous Administration. Molecular Pharmaceutics. 17(8). 2938–2951. 25 indexed citations

17.

Lee, Given, Sifei Han, Enyuan Cao, et al.. (2019). Lymphatic Uptake of Liposomes after Intraperitoneal Administration Primarily Occurs via the Diaphragmatic Lymphatics and is Dependent on Liposome Surface Properties. Molecular Pharmaceutics. 16(12). 4987–4999. 34 indexed citations

18.

Hu, Luojuan, Tim Quach, Sifei Han, et al.. (2016). Glyceride‐Mimetic Prodrugs Incorporating Self‐Immolative Spacers Promote Lymphatic Transport, Avoid First‐Pass Metabolism, and Enhance Oral Bioavailability. Angewandte Chemie International Edition. 55(44). 13700–13705. 55 indexed citations

19.

Hu, Luojuan, Tim Quach, Sifei Han, et al.. (2016). Glyceride‐Mimetic Prodrugs Incorporating Self‐Immolative Spacers Promote Lymphatic Transport, Avoid First‐Pass Metabolism, and Enhance Oral Bioavailability. Angewandte Chemie. 128(44). 13904–13909. 7 indexed citations

20.

Trevaskis, Natalie L., Chun‐Min Lo, Yun Li, et al.. (2006). An Acute and Coincident Increase in FABP Expression and Lymphatic Lipid and Drug Transport Occurs During Intestinal Infusion of Lipid-Based Drug Formulations to Rats. Pharmaceutical Research. 23(8). 1786–1796. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact